Search Results 141-150 of 15573 for TNF

  1. Researchers explore whether senescence-associated secretory phenotype (SASP) is a potential driver of age-related dysfunction - Mayo Clinic

    Growth differentiation factor 15 (GDF15) · Tumor necrosis factor receptor superfamily member 6 (TNFRSF6) · Osteopontin (OPN) · TNF receptor 1 (TNFR1) · Activin A ...

  2. Vedolizumab IV in Pediatric Participants With Ulcerative Colitis or Crohn's Disease - Mayo Clinic

    Tumor necrosis factor-alpha (TNF-α) antagonists: • Signs and symptoms of persistently active disease despite a history of at least 1 induction regimen of ...

  3. A Study to Evaluate Response to Adalimumab in Rheumatoid Arthritis Patients - Mayo Clinic

    ... tumor necrosis factor receptor antagonist in adults with a clinical diagnosis of rheumatoid arthritis. Participation eligibility. Participant eligibility ...

  4. Treatment response and management of biologics in patients with ECD - Mayo Clinic

    A variety of biologic therapies are among the options available for treatment of ECD and other forms of IBD . These include tumor necrosis factor-alpha (TNFα) ...

  5. A Study to Evaluate the Safety and Effectiveness of Ustekinumab as Initial or Maintenance Therapy for Patients with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    Is naïve to biologic therapy (TNF antagonists or vedolizumab); Has received biologic therapy but has not demonstrated a history of failure to respond to, or ...

  6. Study of Efficacy and Safety of CTL019 in Adult ALL Patients - Mayo Clinic

    ... TNF-α, anti-IL6 or anti-IL6R). Topical steroids for localized treatment of GVHD are allowed. Anti T-cell Directed Therapy; Administration of any T cell lytic ...

  7. Publications - Lester E. Mertz, M.D. - Mayo Clinic

    ... Tumor Necrosis Factor alpha. Clin Infect Dis. 2019 Mar 5; 68 (6):1024-1030. View PubMed; Nokes B, Tseng AS, Cartin-Ceba R, Shamoun F, Jokerst C, Mertz L ...

  8. Publications - Ryan W. Stidham, M.D. - Mayo Clinic

    ... TNF-experienced patients with fistulizing Crohn's disease. Therap Adv Gastroenterol. 2023; 16:17562848221148254 Epub 2023 Mar 03. View PubMed; Yu D, Stidham ...

  9. Publications - Shannon P. Fortin Ensign, M.D., Ph.D. - Mayo Clinic

    Tumor necrosis factor-like weak inducer of apoptosis stimulation of glioma cell survival is dependent on Akt2 function. Mol Cancer Res. 2009 Nov; 7: (11)1871-81 ...

  10. Publications - John Mark B. Gubatan, M.D. - Mayo Clinic

    A Similar Mutation in the AAUU-Rich Elements of the Mouse TNF Gene Results in a Distinct Ileocolitic Phenotype: A New Strain of TNF-Overexpressing Mice.